Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial

1. Peters, S.
2. Stahel, R.A.
3. Dafni, U.
4. Ponce Aix, S.
5. Massutí, B.
6. Gautschi, O.
7. Coate, L.
8. López Martín, A.
9. van Heemst, R.
10. Berghmans, T.
11. Meldgaard, P.
12. Cobo Dols, M.
13. Garde Noguera, J.
14. Curioni-Fontecedro, A.
15. Rauch, D.
16. Mark, M.T.
17. Cuffe, S.
18. Biesma, B.
19. van Henten, A.M.J.
20. Juan Vidal, Ó.
21. Palmero Sanchez, R.
22. Villa Guzmán, J.C.
23. Collado Martin, R.
24. Peralta, S.
25. Insa, A.
26. Summers, Y.
27. Láng, I.
28. Horgan, A.
29. Ciardiello, F.
30. de Hosson, S.
31. Pieterman, R.
32. Groen, H.J.M.
33. van den Berg, P.M.
34. Zielinski, C.C.
35. Chittazhathu Kurian Kuruvilla, Y.
36. Gasca-Ruchti, A.
37. Kassapian, M.
38. Novello, S.
39. Torri, V.
40. Tsourti, Z.
41. Gregorc, V.
42. Smit, E.F.
43. Show all authors +